Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours

Technology appraisal guidance
Reference number: TA86
Published: 27 October 2004
Last updated: 01 November 2010

TA86 Gastrointestinal stromal tumours - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive

TA86 Gastrointestinal stromal tumours - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive

TA86 Gastrointestinal stromal tumours - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive
21 October 2013
(108.62 Kb 31 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 October 2013